Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04115046 · ClinicalTrials.gov registry record
The EUS ShearWave Elastography Liver Fibrosis Study
A clinical trial, sponsored by Olympus Corporation of the Americas.
- Completed
- Registry status
- 52
- Enrollment target
NCT04115046: Completed study, sponsored by Olympus Corporation of the Americas.
NCT04115046 is a clinical trial that has completed, run by Olympus Corporation of the Americas. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04115046 has completed, sponsored by Olympus Corporation of the Americas.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The study objective is to demonstrate the clinical performance of ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) when compared to FibroScan for evaluation of liver fibrosis.
Primary Outcome
Use ANOVA with Tukey Range test to evaluate the level of significance of difference in SWE results across fibrosis stages.
Interventions
- DEVICE FibroScan
- DEVICE ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS)
- DEVICE ALOKA ARIETTA 850 -
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2021-05-17 |
What the finished NCT04115046 record still lists
NCT04115046 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which FibroScan is the first listed.
NCT04115046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04115046 about?
NCT04115046 is a clinical study titled "The EUS ShearWave Elastography Liver Fibrosis Study". The study objective is to demonstrate the clinical performance of ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) when compared to FibroScan for evaluation of liver fibrosis.
What is the current status of trial NCT04115046?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2020-07-14. Estimated completion is 2021-05-17.
What interventions are being tested in trial NCT04115046?
The interventions under investigation include: FibroScan (DEVICE), ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) (DEVICE), ALOKA ARIETTA 850 - (DEVICE).
Who is sponsoring clinical trial NCT04115046?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI